Literature DB >> 17032745

Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells.

Liran Zhou1, Hong Wu, Peng Lee, Zhengxin Wang.   

Abstract

Various cofactors have been shown to regulate androgen receptor (AR) transactivation, but their physiological functions in the AR pathway and prostate tumorigenesis are undefined. Here, we found that AR cofactor (p44) translocation from the nucleus to the cytoplasm in prostate epithelial cells (ECs) is associated with prostate tumorigenesis. The forced nuclear localization of p44 inhibited prostate cancer cell growth by G1 cell-cycle arrest. Consistently, mice lacking one allele of the p44 gene developed prostatic hyperplasia. Therefore, p44 is required for proper expression of AR-target genes to maintain the differentiation of prostate ECs, and p44 translocation from the nucleus into the cytoplasm in prostate cancer cells or loss of one allele in mouse results in excessive prostate EC proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032745     DOI: 10.1677/jme.1.02062

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  25 in total

1.  The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer.

Authors:  Z Gu; F Zhang; Z-Q Wang; W Ma; R E Davis; Z Wang
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

Review 2.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

3.  The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss.

Authors:  Deon O'Bryant; Zhengxin Wang
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

Review 4.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

5.  E2F and GATA switches turn off WD repeat domain 77 expression in differentiating cells.

Authors:  Min Yu; Ulrica Wang; Zhengxin Wang
Journal:  Biochem J       Date:  2016-06-07       Impact factor: 3.857

6.  Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.

Authors:  Derek N Lavery; M Angeles Villaronga; Marjorie M Walker; Anup Patel; Borja Belandia; Charlotte L Bevan
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

Review 7.  Androgen receptor coactivators that inhibit prostate cancer growth.

Authors:  Garrett Daniels; Ruchi Jha; Ying Shen; Susan K Logan; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2014-04-05

8.  Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer.

Authors:  Yi Peng; Fei Chen; Jonathan Melamed; Luis Chiriboga; Jianjun Wei; Xiangtian Kong; Maureen McLeod; Yirong Li; Caihong X Li; Alice Feng; Michael J Garabedian; Zhengxin Wang; Robert G Roeder; Peng Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-20       Impact factor: 11.205

9.  LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.

Authors:  Yirong Li; Longgui Wang; Miao Zhang; Jonathan Melamed; Xiaomei Liu; Robert Reiter; Jianjun Wei; Yi Peng; Xuanyi Zou; Angel Pellicer; Michael J Garabedian; Anna Ferrari; Peng Lee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

10.  WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.

Authors:  Mahmood Anber Altayyar; Xiumei Sheng; Zhengxin Wang
Journal:  Mol Cell Biol       Date:  2020-11-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.